Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F17%3A00485880" target="_blank" >RIV/67985823:_____/17:00485880 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68407700:21230/17:00317716 RIV/00216208:11130/17:10373394 RIV/00064203:_____/17:10373394
Výsledek na webu
<a href="http://dx.doi.org/10.3389/fneur.2017.00687" target="_blank" >http://dx.doi.org/10.3389/fneur.2017.00687</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fneur.2017.00687" target="_blank" >10.3389/fneur.2017.00687</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate
Popis výsledku v původním jazyce
Pathological high-frequency oscillations are a novel marker used to improve the delineation of epileptogenic tissue and, hence, the outcome of epilepsy surgery. Their practical clinical utilization is curtailed by the inability to discriminate them from physiological oscillations due to frequency overlap. Although it is well documented that pathological HFOs are suppressed by antiepileptic drugs (AEDs), the effect of AEDs on normal HFOs is not well known. In this experimental study, we have explored whether physiological HFOs (sharp-wave ripples) of hippocampal origin respond to AED treatment. The results show that application of a single dose of levetiracetam or lacosamide does not reduce the rate of sharp-wave ripples. In addition, it seems that these new generation drugs do not negatively affect the cellular and network mechanisms involved in sharp-wave ripple generation, which may provide a plausible explanation for the absence of significant negative effects on cognitive functions of these drugs, particularly on memory.
Název v anglickém jazyce
Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate
Popis výsledku anglicky
Pathological high-frequency oscillations are a novel marker used to improve the delineation of epileptogenic tissue and, hence, the outcome of epilepsy surgery. Their practical clinical utilization is curtailed by the inability to discriminate them from physiological oscillations due to frequency overlap. Although it is well documented that pathological HFOs are suppressed by antiepileptic drugs (AEDs), the effect of AEDs on normal HFOs is not well known. In this experimental study, we have explored whether physiological HFOs (sharp-wave ripples) of hippocampal origin respond to AED treatment. The results show that application of a single dose of levetiracetam or lacosamide does not reduce the rate of sharp-wave ripples. In addition, it seems that these new generation drugs do not negatively affect the cellular and network mechanisms involved in sharp-wave ripple generation, which may provide a plausible explanation for the absence of significant negative effects on cognitive functions of these drugs, particularly on memory.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30103 - Neurosciences (including psychophysiology)
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Frontiers in Neurology
ISSN
1664-2295
e-ISSN
—
Svazek periodika
8
Číslo periodika v rámci svazku
Dec 21
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
7
Strana od-do
—
Kód UT WoS článku
000418671200001
EID výsledku v databázi Scopus
2-s2.0-85039044485